Literature DB >> 8040909

Eikenella corrodens endocarditis in an intravenous drug user: case report and literature review.

L A Olopoenia1, V Mody, M Reynolds.   

Abstract

A rare case of Eikenella corrodens endocarditis in an intravenous drug user is reported. Repeated blood cultures from the patient established the diagnosis of this infection. However, evaluation of the cardiac function using two-dimensional echocardiography with Doppler flow demonstrated a large pedunculated tricuspid vegetation. Also evident on this study was a dilated right ventricle with diminished contractility and regurgitation. Complete sterilization of the blood was achieved after a 2-week course of intravenous penicillin and gentamicin followed by an additional 4-week course of intravenous penicillin alone. Clinicians treating suspected IV drug users should be aware of the potential pathogenicity of this rare, facultative, anaerobic gram-negative bacillus (E corrodens). A combination of intravenous penicillin and aminoglycoside should be considered as the initial treatment followed by an additional course of intravenous penicillin for such patients with valvular vegetation.

Entities:  

Mesh:

Year:  1994        PMID: 8040909      PMCID: PMC2607643     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  12 in total

1.  Eikenella corrodens comes of age.

Authors:  G F Brooks; A White
Journal:  South Med J       Date:  1976-05       Impact factor: 0.954

2.  Eikenella corrodens subacute bacterial endocarditis: mixed infection in amphetamine user.

Authors:  H R Marcus; C M Phelps
Journal:  N Y State J Med       Date:  1977-12

Review 3.  Eikenella corrodens, a recently recognized pathogen: infections in medical-surgical patients and in association with methylphenidate abuse.

Authors:  G F Brooks; J M O'Donoghue; J P Rissing; K Soapes; J W Smith
Journal:  Medicine (Baltimore)       Date:  1974-09       Impact factor: 1.889

4.  Eikenella corrodens endocarditis: report of cure in two cases.

Authors:  J E Geraci; P E Hermans; J A Washington
Journal:  Mayo Clin Proc       Date:  1974-12       Impact factor: 7.616

5.  Infections with Eikenella corrodens. A newly recognized human pathogen.

Authors:  G J Dorff; L J Jackson; M W Rytel
Journal:  Ann Intern Med       Date:  1974-03       Impact factor: 25.391

6.  Eikenella corrodens endocarditis: case report and review of the literature.

Authors:  S J Landis; J Korver
Journal:  Can Med Assoc J       Date:  1983-04-01       Impact factor: 8.262

7.  Eikenella corrodens infections in drug abusers.

Authors:  M Silpa; J D'Angelo
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

8.  Mycotic aneurysm of the sinus of Valsalva due to Eikenella corrodens bacterial endocarditis.

Authors:  A J Burger; F C Messineo; P Schulman; D Geller
Journal:  Cardiology       Date:  1984       Impact factor: 1.869

9.  Infective endocarditis due to anaerobic and microaerophilic bacteria.

Authors:  F L Sapico; R J Sarma
Journal:  West J Med       Date:  1982-07

10.  Polymicrobial endocarditis involving Eikenella corrodens.

Authors:  J D Sobel; J Carrizosa; T F Ziobrowski; S J Gluckman
Journal:  Am J Med Sci       Date:  1981 Jul-Aug       Impact factor: 2.378

View more
  4 in total

1.  Skin and Soft Tissue Infections in Injection Drug Users.

Authors:  Patricia D. Brown; John R. Ebright
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

Review 2.  Endocarditis due to rare and fastidious bacteria.

Authors:  P Brouqui; D Raoult
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

3.  Eikenella corrodens infective endocarditis in a previously healthy non-drug user.

Authors:  R W Watkin; N Baker; S Lang; J Ment
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-11       Impact factor: 3.267

4.  Eikenella corrodens endocarditis and liver abscess in a previously healthy male, a case report.

Authors:  Anne Christine Nordholm; Ruth Ottilia Birgitta Vøgg; Henrik Permin; Terese Katzenstein
Journal:  BMC Infect Dis       Date:  2018-01-12       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.